FIELD: medicine, pharmacology.
SUBSTANCE: the present innovation deals with preparation for treating and preventing inspecific ulcerous colitis that contains N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl) cyclohexane carboxamide or its salt.
EFFECT: increased activity of preparation suggested.
1 cl, 2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING AND PREVENTING PULMONARY DEFICIENCY CONTAINING DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVE | 2001 |
|
RU2253450C2 |
NEW EP4 AGONIST | 2011 |
|
RU2564414C2 |
NOVEL PROSTAGLANDIN I DERIVATIVE | 2009 |
|
RU2509768C2 |
PREVENTIVE OR THERAPEUTIC SUBSTANCE IN CASE OF INFLAMMATORY INTESTINAL DISEASES | 2008 |
|
RU2469724C2 |
COMBINED APPLICATION OF PROSTAGLANDIN DERIVATIVE AND PROTON PUMP INHIBITOR FOR TREATMENT OF GASTROINTESTINAL DISEASES | 2006 |
|
RU2468800C2 |
METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN | 2014 |
|
RU2669800C2 |
THERAPEUTIC MEDICATION FOR INFLAMMATORY INTESTINAL DISEASES WHICH CONTAINS DERIVATIVE OF 2-AMINO-1,3-PROPANDIOL AS ACTIVE INGREDIENT, OR METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2007 |
|
RU2428976C2 |
CYCLOPENTYL DERIVATIVES | 2004 |
|
RU2372325C2 |
PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF | 2009 |
|
RU2479579C2 |
DERIVATIVES OF 2-PHENYLPYRANE-4-ONE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT | 1999 |
|
RU2232158C2 |
Authors
Dates
2005-12-20—Published
2001-01-30—Filed